Journal of Pharmaceutical Investigation

  • 제33권2호
  • /
  • Pages.113-120
  • /
  • 2003
  • /
  • 2093-5552(pISSN)
  • /
  • 2093-6214(eISSN)
한국약제학회 (The Korean Society of Pharmaceutical Sciences and Technology)
권호 표지
DOI QR코드

DOI QR Code

다시마 식이가 흰쥐에서 글리피지드의 체내동태에 미치는 영향

The Effect of Laminaria japonica Diet on the Pharmacokinetics of Glipizide in Rats

  • 발행 : 2003.06.20
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Drug interactions with food, on occasion, lead to serious nutritional and functional changes in the body as well as alternations of pharmacological effect. It, therefore, should be necessary to take drug interactions with food into consideration for effective and safe therapeutics. Diabetes mellitus is a heterogeneous group of disorders characterized by abnormal glucose homeostasis, resulting in hyperglycemia, and is associated with increased risk of micovascular, macrovascular, and neuropathic complications. However, the precise mechanism of diabetes mellitus remains unclear. Three basic objectives in the care of diabetic patients are maintaining optimal nutrition, avoiding hypo- or hyperglycemia and preventing complications. The purpose of this study was to investigate thε effect of Laminaria japonica diet on the absorption, distribution, metabolism and excretion of glipizide which are frequently used in the treatment of diabetes. Diabetic rats induced by streptozotocin were employed in this study. Blood concentrations of oral hypoglycemic agents were measured by HPLC and resultant pharmacokinetic parameters were calculated by RSTRIP. The mechanisms of drug interaction with food were evaluated on the basis of pharmacokinetic parameters such as $k_{a},\;t_{1/2},\;C_{max},\;t_{max}$ and AUC. Administration of glipizide in normal rats treated with Laminaria japonica diet showed significant increase in AUC, $k_{a},\;t_{1/2},\;t_{max}$ and decrease in $C_{max}$, compared to those without Laminaria japonica diet. This might result from adsorption of glipizide on components of Laminaria japonica, causing delayed absorption. Administration of glipizide in diabetic rats treated with Laminaria japonica diet showed significant increase in $t_{1/2}\;and\;t_{max}$, and decrease in $C_{max}$, compared to those without Laminaria japonica diet. This might also result from adsorption of glipizide on components of Laminaria japonica, causing delayed absorption and flattened blood concentration of glipizide. The oral glucose test showed that Laminaria japonica diet could lower blood glucose level probably through either inhibiting the activity of disaccharidases, intestinal digestive enzymes, or delaying the absorption of glucose. More studies should be followed to fully understand pharmacokinetic changes of glipizide caused by long-term Laminaria japonica diet.

키워드

참고문헌

  1. D.A. Roe, Therapeutic significance of drug-nutrient interac-tiori in the elderly, Pharmcol. Rev; 36, 109s-121s (1984)
  2. I. Torsdottir, M. Alpsten, G. Holm, AS. Sandberg and J. Tolli, A small dose of soluble alginate-fiber affects postprandial glycemia and emptying in humans with diabetes, J. Nutr., 121, 795-798 (1991) https://doi.org/10.1093/jn/121.6.795
  3. P.P. Lamy, Effects of diet and nutrition on drug theraphy, J. Am. Geriat. Soc., 30, 99s-111s (1982) https://doi.org/10.1111/j.1532-5415.1982.tb01364.x
  4. R.E. Notari; Biopharmaceutics and Clinical Pharmacokinetics; Marcel Dekker, New York, 1987
  5. H. King, R.E. Aubert, WH. Herman, Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections, Diabetes Care, 21, 1414-1431 (1998) https://doi.org/10.2337/diacare.21.9.1414
  6. 박정난, 식이섬유질의 종류와 함량이 장의 기능과 형태에 미치는 영향, 한양대학교 대학원 석사학위 논문, 1992
  7. B. Flourie, N. Vidon, C.H. Florent and J.J. Bernier, Effect of pectin on jejunal glucose absorption and unstatified layer thickness in normal man, Gut, 25, 936-939 (1984) https://doi.org/10.1136/gut.25.9.936
  8. K.W. Woodhouse and O.F.W. James, Hepatic drug metabolism and aging, Br. Med. Bulletin, 46, 22-35 (1990) https://doi.org/10.1093/oxfordjournals.bmb.a072387
  9. R.M. Wayne, Metformin: an antihyperglycemic agent for treatment of type diabetes, Ann. Pharmacother., 30, 158-64(1996) https://doi.org/10.1177/106002809603000210
  10. W.J. MacLennan, The aging society, Br. J. Hospital Med., 39, 112-120 (1988)
  11. A Melander, K. Danielson, B. Schesten and E. Wahlin, Enhancement of the bioavailability of propranolol and metprolol by food, Clin. Pharmacol. Ther., 22, 108-112 (1977) https://doi.org/10.1002/cpt1977221108
  12. L. Z. Benet, N. Massoud and J. G. Gambertoglio, Pharmacokinetic Basis for Drug Treatment, Raven press, New York, 1983
  13. M. Gibaldi and D. Perrier, Pharmacokinetics, 2nd ed., Marcel Dekker, New York, 1982
  14. N. Paul, Transfer of metformin across monolayers of humen interstinal caco-2 cells and across rat intestine, Int. J. Pharm., 128, 155-62 (1996)
  15. Y Min, L.S. Guang, Q.Y Zhi, YX Yong, Pharmacokinetics and bioavailability of glipizide tablets in healthy volunteers, Zhong Guo Yao Xue Zha Zhi(中國藥學雜志), 30, 218-221 (1995)
  16. L.C. Groop, Sulphonylureas in NIDDM, Diabetes Care, 15, 737-754 (1992) https://doi.org/10.2337/diacare.15.6.737
  17. M.L. Chen, G. Lam, M.G. Lee, and W.L. Chiou, Arterial and venous blood sampling in pharmacokinetic study: Griseofulvin, J. Pharm. Sci., 71, 1386-1389 (1982) https://doi.org/10.1002/jps.2600711219
  18. W.L. Chiou, C.Y. Lui, and G. Lam, Plasma area method in relative bioavailability evaluation of drugs with chaging biological half-lives, J. Pharm. Sci., 70, 109-112 (1981) https://doi.org/10.1002/jps.2600700129
  19. N. Takasu, M. Komatsu, T. Aizawa, Y. Nagasawa and T. Yamada, Alloxan-induced DNA strand breaks in pancreatic islets. Evidence for $H_2O_2$ as an intermediate, J. Biol. Chem., 266, 2112-2114 (1991)
  20. X.R. Qing, X.Z. Lin, Determination of glipizide in human plasma by RP-HPLC, Zhong Guo Yi Yuan Yao Xue Zha Zhi (中國醫院藥學雜志), 14, 451-452 (1994)
  21. E. Wahlin-Boll and A. Melander, High-performance liquid chromatographic determination of glipizide and some other sulfonylurea drugs in serum, J. Chromatogr, 164, 541-546(1979) https://doi.org/10.1016/S0378-4347(00)81560-1
  22. Q.C. Chen and C.Q. Yang, Pharmacokinetics and bioavalability of glipizide, Yao Xue Xue Bao, 30, 476-80 (1995)
  23. X.R. Qing, D.S. Shan, Pharmacokinetics and relative bioavailability of glipizide tablets and capsules in healthy volunteers, Zhong Guo Yao Xue Za Zhi, 30, 353-355 (1995)
  24. M.L. Ramson, RSTRIP-polyexponential Curve Stripping/least Square Parameter Estimation, User Handbook, Micromath. Inc., Salt Lake City, Utha, 1987
  25. H.G. Boxenbaum, S. Riegelman and R.M. Elashoff, Statistical estimation in pharmacokinetics, J. Pharmacokin. Biopharm., 2, 123-148 (1974) https://doi.org/10.1007/BF01061504
  26. K. Yamaoka, T. Nakagawa, and T. Uno, Application of Akaike's information creterion (AlC) in the evaluation of linear pharmacokinetic equations, J. Pharmacokin. Biopharm., 6, 165-175 (1978) https://doi.org/10.1007/BF01117450
  27. R.D. Purves, Optimum numerical integration methods for estimation of area under the curve(AUC) and area under the moment curve (AUMC), J. Pharmacokinet. Biopharm., 20, 211-216 (1992) https://doi.org/10.1007/BF01062525
  28. W.L. Chiou, New calculation method for mean apparent drug volume of distribution and application to rational dosage regimen, J. Pharm. Sci., 68, 1068-1069 (1979).
  29. F.M. Al-awadi, M.A. Khattar and A. Gumaa, On the mechanism of the hypoglycemic effect of a plant extract, Diabetologia, 28, 432-434 (1985) https://doi.org/10.1007/BF00280886
  30. R.H. Thomson, Colorimetric glucose oxidase method for blood glucose, Clin. CUm. Acta, 13, 133-135 (1966) https://doi.org/10.1016/0009-8981(66)90281-6
  31. H.A. Schmidt, M. Schoog, K.H. Schweer and E. Winkler, Pharmacokinetics and pharmacodynamics as well as metabolism following orally and intravenously administered C14glipizide, a new antidiabetic, Diabetologia, Sep, 320-330 (1973).
  32. D.J. Jenkins, T.M. Wolever, A.R. Leeds, M.A Gassull, P. Haisman, J. Dilawari, D.V. Goff, G.L. Metz and K.G. Alberti, Dietary fibers, fiber analogues, and glucose tolerance: importance of viscosity, Br. Med. J, 1, 1392-1394 (1978) https://doi.org/10.1136/bmj.1.6124.1392
  33. B.O. Schneeman, Pancreatic and digestive function. In: Vahouny G.V., Kritchevsky D., eds. Dietary fibre in health and disease. New York: Plenum Press, pp. 72-83, 1982
  34. G. Semenza, Anchoring and biosynthesis of stalk brush border membrane protein: glucosidases and peptidases of enterocytes and renal tubuli, Ann. Rev. Cell BioI., 2, 255-313 (1986). https://doi.org/10.1146/annurev.cb.02.110186.001351
  35. C.D. Nandini, K. Sambaiah and P.V.Salimath, Effect ofdietary fibre on intestinal and renal disaccharides in diabetic rats, Nutr. Res., 20, 1301-1307 (2000) https://doi.org/10.1016/S0271-5317(00)00213-X
  36. S. Khokhar, Dietary fibre, their effect on intestinal digestive enzyme activities, J. Nutr. Biochem., 5, 176-180 (1994) https://doi.org/10.1016/0955-2863(94)90069-8
  37. D.J.A. Jenkins, C.W.C. Kendall, L.S.A. Augustin and V. Vuskan, High-complex carbohydrate or lente carbohydrate foods, Am. J. Med., 113, 30s-37s (2002)